fda sued over tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly targets FDA approval

Thus, it is postulated that DCS Class IIa substances would only require dissolution rate enhancement through traditional formulation approaches (e.g., surfactants, salts), while BCS IIb substances would demand alternative strategies (e.g., amorphous solid dispersions, nanoparticles)

2008 Dec;18(6):567-84

If you experience significant nausea: Try moving your next dose to the thigh

Taking the first step starts with a conversation

No digestion, no break down of the product, just pure glutathione that is delivered straight to your bloodstream and therefore to every cell in your body

Although the National Institute of Health (NIH) still claims that GSH deficiency is very rare, there is growing number of reputable sources that state quite the opposite